The page you were trying to view does not exists or may have expired. Below are the list of similar positions in our database.
Similar Posts
-
School of Engineering Sciences in Chemistry, Biotechnology and Health at KTH Job description KTH Royal Institute of Technology in Stockholm has grown to become one of Europe’s leading technical and
-
of Public Health and Human Longevity Science, and our Student Health and Well-Being Department. We have long been at the forefront of translational - or "bench-to-bedside" - research, transforming patient
-
the goal of improving human health. Aligned with Rutgers University–New Brunswick and collaborating university wide, RBHS includes eight schools, a behavioral health network, and six centers and institutes
-
, multidisciplinary research is carried out based on DNA sequencing, gene expression analysis, proteomics, bioinformatics, biostatistics and system biology. The goal is to enable Swedish researchers to analyze genes
-
hospitals and clinics; the basic and public health research and outreach of San Diego State University (SDSU), and the basic and translational research of the La Jolla Institute of Immunology (LJI
-
development of the next generation of physicians, scientists, pharmacists and health professionals; we discover and translate new knowledge in the biomedical and health sciences; we provide cutting-edge
-
, quality control and quality assurance. The research associate should have tissue culture experience (human cell line and stem cell preferred) in order to be trained in GMP grade culture of continuous human
-
area. MCW is a distinguished leader and innovator in the education and development of the next generation of physicians, scientists, pharmacists and health professionals; we discover and translate new
-
the goal of improving human health. Aligned with Rutgers University–New Brunswick and collaborating university wide, RBHS includes eight schools, a behavioral health network, and six centers and institutes
-
, alone or in combination with gene expression fingerprints and/or peripheral blood biomarkers, to treat patients based on the genetic subtype of IPF they have, and to initiate treatment in the preclinical